Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of its Microbiology Business to Astorg

Axinn advised Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, on its definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for approximately $1.075 billion. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing.

 The Axinn team includes partners James Hunsberger and Mark Alexander and associates Megan Walden and Leandra Ipiña.

 More details can be found here.

 About Axinn

Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth, always thinking ahead.